Skip to main content
Erschienen in: Clinical Rheumatology 7/2023

06.03.2023 | BRIEF REPORT

Barriers and facilitators for physical activity in rheumatic and musculoskeletal disease: a European-based survey

verfasst von: George S. Metsios, S. A. M. Fenton, K. Tzika, R. H. Moe, G. E. Fragoulis, T. P. M. Vliet Vlieland, E. Nikiphorou, C. H. M. Van den Ende, I. Fatouros, M. van der Esch, K. Niedermann, A. Stavropoulos-Kalinoglou, J. J. C. S. Veldhuijzen van Zanten, N. Brodin, C. M. O’Brien, Y. Koutedakis, N. Kennedy, T. W. Swinnen, C. Bostrom, G. D. Kitas, The IMPACT-RMD Consortium

Erschienen in: Clinical Rheumatology | Ausgabe 7/2023

Einloggen, um Zugang zu erhalten

Abstract

Physical activity (PA) is a key strategy for improving symptoms in people with rheumatic and musculoskeletal diseases (RMDs). The aim of this study was to investigate and rank the importance of known barriers and facilitators for engaging in PA, from the perspective of people living with RMD. Five hundred thirty-three people with RMD responded to a survey (nine questions) disseminated by the People with Arthritis and Rheumatism (PARE) network of the European Alliance of Associations for Rheumatology (EULAR). The survey required participants to rank — based on their perceived importance — known PA barriers and facilitators from the literature, and specifically RMD symptoms as well as healthcare and community factors that may affect PA participation. Of the participants, 58% reported rheumatoid arthritis as their primary diagnosis, 89% were female, and 59% were between 51 and 70 years of age. Overall, participants reported fatigue (61.4%), pain (53.6%) and painful/swollen joints (50.6%) as the highest ranked barriers for engaging in PA. Conversely, less fatigue (66.8%) and pain (63.6%), and being able to do daily activities more easy (56.3%) were identified as the most important facilitators to PA. Three literature identified PA barriers, i.e., general health (78.8%), fitness (75.3%) and mental health (68.1%), were also ranked as being the most important for PA engagement. Symptoms of RMDs, such as pain and fatigue, seem to be considered the predominant barriers to PA by people with RMD; the same barriers are also the ones that they want to improve through increasing PA, suggesting a bi-directional relationship between these factors.
Key Points
Symptoms of rheumatic and musculoskeletal disease (RMD) are the predominant barriers for lack of physical activity engagement.
RMD symptoms are the factors that people with RMDs want to improve when engaging in PA.
The barriers that stop people living with RMDs to do more PA are the ones that can be significantly improved through PA engagement.
Literatur
1.
Zurück zum Zitat Metsios GS, Moe RH, Kitas GD (2020) Exercise and inflammation. Best Pract Res Clin Rheumatol 34(2):101504CrossRefPubMed Metsios GS, Moe RH, Kitas GD (2020) Exercise and inflammation. Best Pract Res Clin Rheumatol 34(2):101504CrossRefPubMed
2.
Zurück zum Zitat Metsios GS, Moe RH, van der Esch M, van Zanten J, Fenton SAM, Koutedakis Y et al (2019) The effects of exercise on cardiovascular disease risk factors and cardiovascular physiology in rheumatoid arthritis. Rheumatol Int 40(3):347–357. https://doi.org/10.1007/s00296-019-04483-6 Metsios GS, Moe RH, van der Esch M, van Zanten J, Fenton SAM, Koutedakis Y et al (2019) The effects of exercise on cardiovascular disease risk factors and cardiovascular physiology in rheumatoid arthritis. Rheumatol Int 40(3):347–357. https://​doi.​org/​10.​1007/​s00296-019-04483-6
3.
Zurück zum Zitat Rausch Osthoff AK, Niedermann K, Braun J, Adams J, Brodin N, Dagfinrud H et al (2018) 2018 EULAR recommendations for physical activity in people with inflammatory arthritis and osteoarthritis. Ann Rheum Dis 77:1251–1260 Rausch Osthoff AK, Niedermann K, Braun J, Adams J, Brodin N, Dagfinrud H et al (2018) 2018 EULAR recommendations for physical activity in people with inflammatory arthritis and osteoarthritis. Ann Rheum Dis 77:1251–1260
4.
Zurück zum Zitat Agca R, Heslinga SC, Rollefstad S, Heslinga M, McInnes IB, Peters MJ et al (2017) EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis 76(1):17–28CrossRefPubMed Agca R, Heslinga SC, Rollefstad S, Heslinga M, McInnes IB, Peters MJ et al (2017) EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis 76(1):17–28CrossRefPubMed
5.
Zurück zum Zitat Veldhuijzen van Zanten JJ, Rouse PC, Hale ED, Ntoumanis N, Metsios GS, Duda JL et al (2015) Perceived barriers, facilitators and benefits for regular physical activity and exercise in patients with rheumatoid arthritis: a review of the literature. Sports Med 45(10):1401–12CrossRefPubMedPubMedCentral Veldhuijzen van Zanten JJ, Rouse PC, Hale ED, Ntoumanis N, Metsios GS, Duda JL et al (2015) Perceived barriers, facilitators and benefits for regular physical activity and exercise in patients with rheumatoid arthritis: a review of the literature. Sports Med 45(10):1401–12CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Niedermann K, Nast I, Ciurea A, Vliet Vlieland T, van Bodegom-Vos L (2019) Barriers and facilitators of vigorous cardiorespiratory training in axial spondyloarthritis: surveys among patients, physiotherapists, and rheumatologists. Arthritis Care Res (Hoboken) 71(6):839–851CrossRefPubMed Niedermann K, Nast I, Ciurea A, Vliet Vlieland T, van Bodegom-Vos L (2019) Barriers and facilitators of vigorous cardiorespiratory training in axial spondyloarthritis: surveys among patients, physiotherapists, and rheumatologists. Arthritis Care Res (Hoboken) 71(6):839–851CrossRefPubMed
7.
Zurück zum Zitat Harb S, Pelaez S, Carrier ME, Kwakkenbos L, Bartlett SJ, Hudson M, et al (2021) Barriers and facilitators to physical activity for people with scleroderma: a scleroderma patient-centered intervention network cohort study. Arthritis Care Res (Hoboken) Harb S, Pelaez S, Carrier ME, Kwakkenbos L, Bartlett SJ, Hudson M, et al (2021) Barriers and facilitators to physical activity for people with scleroderma: a scleroderma patient-centered intervention network cohort study. Arthritis Care Res (Hoboken)
8.
Zurück zum Zitat Metsios GS, Koutedakis Y, Veldhuijzen van Zanten JJ, Stavropoulos-Kalinoglou A, Vitalis P, Duda JL et al (2015) Cardiorespiratory fitness levels and their association with cardiovascular profile in patients with rheumatoid arthritis: a cross-sectional study. Rheumatology (Oxford) 54(12):2215–20PubMed Metsios GS, Koutedakis Y, Veldhuijzen van Zanten JJ, Stavropoulos-Kalinoglou A, Vitalis P, Duda JL et al (2015) Cardiorespiratory fitness levels and their association with cardiovascular profile in patients with rheumatoid arthritis: a cross-sectional study. Rheumatology (Oxford) 54(12):2215–20PubMed
9.
Zurück zum Zitat Sobejana M, van den Hoek J, Metsios GS, Kitas GD, Jorstad HT, van der Leeden M et al (2021) Cardiorespiratory fitness and physical activity in people who have rheumatoid arthritis at an increased risk of cardiovascular disease: a cross-sectional study. Rheumatol Int 41(12):2177–2183CrossRefPubMed Sobejana M, van den Hoek J, Metsios GS, Kitas GD, Jorstad HT, van der Leeden M et al (2021) Cardiorespiratory fitness and physical activity in people who have rheumatoid arthritis at an increased risk of cardiovascular disease: a cross-sectional study. Rheumatol Int 41(12):2177–2183CrossRefPubMed
10.
Zurück zum Zitat Metsios GS, Fenton SAM, Moe HR, van der Esch M, Veldhuijzen van Zanten JJCS, Koutedakis Y et al (2019) Implementation of physical activity into routine clinical practice in rheumatic musculoskeletal disease: the IMPACT-RMD study protocol and rationale. Mediterr J Rheumatol 30(4):231–6CrossRefPubMedPubMedCentral Metsios GS, Fenton SAM, Moe HR, van der Esch M, Veldhuijzen van Zanten JJCS, Koutedakis Y et al (2019) Implementation of physical activity into routine clinical practice in rheumatic musculoskeletal disease: the IMPACT-RMD study protocol and rationale. Mediterr J Rheumatol 30(4):231–6CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Hurkmans E, Giesenvander FJ, Vliet Vlieland TP, Schoones J, Van den Ende EC (2009) Dynamic exercise programs (aerobic capacity and/or muscle strength training) in patients with rheumatoid arthritis. Cochrane Database Syst Rev 2009(4):CD006853 PubMedPubMedCentral Hurkmans E, Giesenvander FJ, Vliet Vlieland TP, Schoones J, Van den Ende EC (2009) Dynamic exercise programs (aerobic capacity and/or muscle strength training) in patients with rheumatoid arthritis. Cochrane Database Syst Rev 2009(4):CD006853 PubMedPubMedCentral
12.
Zurück zum Zitat Rongen-van Dartel SA, Repping-Wuts H, Flendrie M, Bleijenberg G, Metsios GS, van den Hout WB et al (2015) Effect of aerobic exercise training on fatigue in rheumatoid arthritis: a meta-analysis. Arthritis Care Res (Hoboken) 67(8):1054–1062CrossRefPubMed Rongen-van Dartel SA, Repping-Wuts H, Flendrie M, Bleijenberg G, Metsios GS, van den Hout WB et al (2015) Effect of aerobic exercise training on fatigue in rheumatoid arthritis: a meta-analysis. Arthritis Care Res (Hoboken) 67(8):1054–1062CrossRefPubMed
13.
Zurück zum Zitat O’Brien CM, Ntoumanis N, Duda JL, Kitas GD, Veldhuijzen van Zanten J, Metsios GS et al (2021) Pain and fatigue are longitudinally and bi-directionally associated with more sedentary time and less standing time in rheumatoid arthritis. Rheumatology (Oxford) 60(10):4548–57CrossRefPubMed O’Brien CM, Ntoumanis N, Duda JL, Kitas GD, Veldhuijzen van Zanten J, Metsios GS et al (2021) Pain and fatigue are longitudinally and bi-directionally associated with more sedentary time and less standing time in rheumatoid arthritis. Rheumatology (Oxford) 60(10):4548–57CrossRefPubMed
14.
Zurück zum Zitat Metsios GS, Kitas GD (2020) Should patients with rheumatic diseases take pain medication in order to engage in exercise? Expert Rev Clin Immunol 16(3):235–237CrossRefPubMed Metsios GS, Kitas GD (2020) Should patients with rheumatic diseases take pain medication in order to engage in exercise? Expert Rev Clin Immunol 16(3):235–237CrossRefPubMed
15.
Zurück zum Zitat Davergne T, Tekaya R, Sellam J, Tournadre A, Mitrovic S, Ruyssen-Witrand A et al (2021) Influence of perceived barriers and facilitators for physical activity on physical activity levels in patients with rheumatoid arthritis or spondyloarthritis: a cross-sectional study of 150 patients. BMC Musculoskelet Disord 22(1):915CrossRefPubMedPubMedCentral Davergne T, Tekaya R, Sellam J, Tournadre A, Mitrovic S, Ruyssen-Witrand A et al (2021) Influence of perceived barriers and facilitators for physical activity on physical activity levels in patients with rheumatoid arthritis or spondyloarthritis: a cross-sectional study of 150 patients. BMC Musculoskelet Disord 22(1):915CrossRefPubMedPubMedCentral
Metadaten
Titel
Barriers and facilitators for physical activity in rheumatic and musculoskeletal disease: a European-based survey
verfasst von
George S. Metsios
S. A. M. Fenton
K. Tzika
R. H. Moe
G. E. Fragoulis
T. P. M. Vliet Vlieland
E. Nikiphorou
C. H. M. Van den Ende
I. Fatouros
M. van der Esch
K. Niedermann
A. Stavropoulos-Kalinoglou
J. J. C. S. Veldhuijzen van Zanten
N. Brodin
C. M. O’Brien
Y. Koutedakis
N. Kennedy
T. W. Swinnen
C. Bostrom
G. D. Kitas
The IMPACT-RMD Consortium
Publikationsdatum
06.03.2023
Verlag
Springer International Publishing
Erschienen in
Clinical Rheumatology / Ausgabe 7/2023
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-023-06518-7

Weitere Artikel der Ausgabe 7/2023

Clinical Rheumatology 7/2023 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Wie managen Sie die schmerzhafte diabetische Polyneuropathie?

10.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Mit Capsaicin-Pflastern steht eine neue innovative Therapie bei schmerzhafter diabetischer Polyneuropathie zur Verfügung. Bei therapierefraktären Schmerzen stellt die Hochfrequenz-Rückenmarkstimulation eine adäquate Option dar.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.